4% Tetrasodium EDTA to Prevent Central Venous Access Device–Associated Complications

This study evaluated whether addition of a locking fluid containing 4% tetrasodium EDTA (t-EDTA) reduced central venous access device (CVAD) complications compared with usual care among adults in intensive care units (ICUs).

Publication Details

Journal
JAMA
Published
2026-05-18
DOI
https://doi.org/10.1001/jama.2026.7399
Primary Topic
Central Venous Catheters and Hemodialysis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

4% Tetrasodium EDTA to Prevent Central Venous Access Device–Associated Complications

JAMA
Central Venous Catheters and Hemodialysis
article

4% Tetrasodium EDTA to Prevent Central Venous Access Device–Associated Complications

article en

Abstract

This study evaluated whether addition of a locking fluid containing 4% tetrasodium EDTA (t-EDTA) reduced central venous access device (CVAD) complications compared with usual care among adults in intensive care units (ICUs).

JAMA
Openalex Percentile: Top 4%
Central Venous Catheters and Hemodialysis
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.